How to Save

Active Duty Military and Veterans: We’re Here to Support You

Multiple savings programs - including Compassionate Care, our flagship program designed to make fertility treatments more affordable - are available to active, veteran and retired members of the US military.

For active military, we recommend downloading this brochure, which covers common infertility FAQ.

Compassionate Care

Designed for Active Military Personnel and Veterans

The Compassionate Care Program provides eligible† patients savings based on income. Eligible active, veteran or retired US military receive a minimum of 25% off and might be eligible for additional savings up to 50% or 75% off the self-pay price of EMD Serono’s fertility medications.

Eligibility is based on qualifying annual household gross income and first-time participation in the Compassionate Care Program. Program is available only at participating pharmacies. Patients must present a valid prescription for an eligible drug

Eligible patients can use the Compassionate Care Program for multiple cycles each year

Qualifying patients can save 75%, 50%, or 25% off the available self-pay price at the participating pharmacy

Eligible active, veteran or retired US military receive a minimum of 25% off and might be eligible for additional savings up to 50% or 75% off the self-pay price of select EMD Serono Fertility medication

Patients must present a valid prescription for an eligible drug at a participating pharmacy

EMD Serono reserves the right to rescind, revoke, terminate, or amend the Compassionate Care Program at any time without notice

Offer not valid for prescriptions that may be covered under private or public insurance or reimbursed under a federal or state healthcare program, including Medicare, Medicaid, TRICARE, the Department of Veterans Affairs, the Department of Defense, or any other similar state healthcare program, including any state medical pharmaceutical assistance program. If you become insured by any private or government insurance you must notify the EMD Serono Compassionate Care program by calling 1-855-541-5926

Patients may not combine this program with any rebate, coupon, free trial, or similar offer

Offer is not transferable and expires one year after program enrollment, unless earlier terminated by EMD Serono

Compassionate Corps

Designed for Veterans with Service-Related Injuries Impacting Fertility

You served our country’s needs, and now we’re here to serve yours.

If you’re a veteran or the spouse of a veteran who’s suffering from infertility because of a service-related injury, you may be eligible† for the Compassionate Corps Program. This program provides free fertility medication to those who are eligible.

The Compassionate Corps Program helps expand EMD Serono Fertility’s mission of advocating for people who want to have a child.

†To be eligible for the Compassionate Corps Program, you must:

Be a retired member of the military or the spouse of one

Be a veteran or the spouse of a veteran who is:

Infertile due to a service-related injury

Not privately or publicly insured for infertility medications

Medically retired

Have been diagnosed by a physician as infertile and requiring IVF (in vitro fertilization)/ART (assisted reproductive technology)

The Compassionate Corps Program is available for up to two cycles per year

Patients must reapply each year

Patients may not combine this offer with any rebate, coupon, free trial card, or similar offer

EMD Serono reserves the right to rescind, revoke, terminate, or amend the Compassionate Corps Program at any time without notice

Offer not valid for prescriptions that may be covered under private or public insurance or reimbursed under a federal or state healthcare program, including Medicare, Medicaid, TRICARE, the Department of Veterans Affairs, the Department of Defense, or any other similar state healthcare program, including any state medical pharmaceutical assistance program. If you become insured by any private or government insurance, you must notify the EMD Serono Compassionate Corps Program by calling 1-855-541-5926

Compassionate Corps is not an insurance program

1. Click here or call 1-866-538-7879to obtain the Compassionate Corps enrollment and Authorization to Use and Disclose Health and Other Personal Information forms.

2. In order to apply for the Compassionate Corps Program, a patient’s fertility center must participate in the program. Find centers currently participating here. To become a participating member, centers can contact EMD Serono directly at Fertility.Marketing@EMDSerono.com.

have a tumor in your female organs, including your ovaries, breast, or uterus

have a tumor in your brain, such as a tumor in your pituitary or hypothalamus

have abnormal bleeding from your uterus or vagina

have ovarian cysts or large ovaries, not due to polycystic ovary syndrome (PCOS)

Before you use Gonal-f® RFF* Redi-ject®, tell your healthcare provider if you:

have or have had asthma

have been told by a healthcare provider that you have an increased risk for blood clots (thrombosis)

have ever had a blood clot (thrombosis), or anyone in your family has ever had a blood clot (thrombosis)

have had abdominal surgery

have had twisting of your ovary (ovarian torsion)

had or have a cyst on your ovary

have polycystic ovarian disease

have any other medical conditions

are breastfeeding or plan to breastfeed

are taking any other prescription or over-the-counter medicines, vitamins, and herbal supplements

Gonal-f® RFF* Redi-ject®may cause serious side effects, including:

severe allergic reactions in women who have used Gonal-f®, Gonal-f® RFF*, or Gonal-f® RFF* Redi-ject® in the past. New allergic reactions can occur immediately after an injection. Severe allergic reaction may lead to death. If you have any of the following symptoms of a severe allergic reaction, stop using Gonal-f® RFF* Redi-ject® and go to the hospital right away:

shortness of breath

swelling of your face

itchy, red bumps or rash on your skin (hives)

ovaries that are too large; symptoms of bloating or pain in your lower stomach (pelvic) area.

ovarian hyperstimulation syndrome (OHSS); a serious medical condition that can happen when your ovaries produce too many eggs (overstimulated). OHSS can cause fluid to suddenly build up in the area of your stomach, chest, and heart, and can cause blood clots to form. In rare cases OHSS has caused death. OHSS may also happen after you stop using Gonal-f® RFF* Redi-ject®. Stop using Gonal-f® RFF* Redi-ject® and call your healthcare provider right away if you have symptoms of OHSS, including:

twisting (torsion) of your ovary if you already have certain conditions such as ovarian cysts, OHSS, pregnancy and previous abdominal surgery. Twisting of your ovary may lead to blood flow being cut off to your ovary.

pregnancy with more than 1 baby and birth of multiple babies; Having a pregnancy and giving birth to multiple babies at a time increases the health risk for you and your babies. Your healthcare provider should tell you about your chances of multiple births.

birth defects in a baby born after an ART cycle (IVF or ICSI). Your chances of having a baby with birth defects may increase depending on:

your age

certain sperm problems

your genetic background and that of your partner

a pregnancy with more than 1 baby at a time

ectopic pregnancy (pregnancy outside your womb). Your chance of having a pregnancy outside of your womb is increased if you also have fallopian tube problems.

miscarriage. Your chance of loss of an early pregnancy may be increased if you had difficulty becoming pregnant.

tumors of the ovary. If you have used fertility medicines like Gonal-f® RFF* Redi-ject® (follitropin alfa injection) before to get pregnant, you may have an increased chance of having tumors in your ovary(ies) (including cancer).

The most common side effects of Gonal-f® RFF* Redi-ject® include:

headache

stomach pain

stomach bloating

bruising at the injection site

nausea

These are not all the possible side effects of Gonal-f® RFF* Redi-ject®. For more information, call your healthcare provider or pharmacist. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Do not share your Gonal-f® RFF* Redi-ject® and needles with another person. You may give another person an infection or get an infection from them.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Also read the Gonal-f® RFF* Redi-ject® “Instructions for Use” that comes with Pen for information about the correct use of Gonal-f® RFF* Redi-ject® and follow all training and instruction provided by your healthcare provider.

Who should not use Gonal-f® (follitropin alfa for injection) and Gonal-f® RFF* (follitropin alfa for injection)?

Gonal-f® Multi-Dose and Gonal-f® RFF* should not be used in patients who are pregnant or think they might be pregnant, in patients with primary ovarian failure (the ovaries no longer produce eggs), or in patients with allergies to recombinant human FSH products or any other ingredients in the medication.

Patients with cancer of the sex organs or brain, or with uncontrolled thyroid or adrenal disease, should not use Gonal-f® Multi-Dose or Gonal-f® RFF*. Women with a history of abnormal bleeding from the uterus or vagina or with swollen, enlarged, or painful ovaries should speak to their doctor before starting treatment.

What are the possible side effects of Gonal-f® and Gonal-f® RFF*?

The lowest dose expected to achieve the desired results should be used. A doctor should monitor a woman’s response often to avoid overdose, which can lead to serious side effects, including blood clots.

Women should contact their doctor if severe pain or bloating in the stomach or pelvic area, severe upset stomach, vomiting, or weight gain are experienced during treatment. These could be signs of a rare but serious condition known as Ovarian Hyperstimulation Syndrome, or OHSS, which can result in hospitalization.

Use of Gonal-f® Multi-Dose or Gonal-f® RFF* by a woman can be associated with fertilization of more than 1 egg. This can lead to complications for the woman and the birth of 2 or more babies.

The most common side effects reported by women were headache, ovarian cysts, upset stomach, and sinus infection. The most common side effects reported by men taking Gonal-f® Multi-Dose were skin pimples, breast pain and growth, and tiredness. Injections may cause some discomfort.

What are the uses of Gonal-f® (follitropin alfa for injection) and Gonal-f®RFF* (follitropin alfa for injection)?

Gonal-f® Multi-Dose and Gonal-f® RFF* are 2 products that contain follitropin alfa, which is similar to the human hormone follicle-stimulating hormone, referred to as FSH. FSH belongs to a group of human reproductive hormones.

Gonal-f® Multi-Dose and Gonal-f® RFF* are used in certain infertile women to help with ovulation (production and release of a mature egg) and pregnancy. Gonal-f® will not help women whose ovaries no longer work because of a condition called Primary Ovarian Failure. Gonal-f® may also be used in women who are in an Assisted Reproductive Technology (ART) program such as in vitro fertilization to help their ovaries make more eggs.

Gonal-f® Multi-Dose can also be prescribed to increase sperm production in men with a rare condition that affects sperm production.

Both products should be prescribed only by doctors specializing in infertility problems and their treatment.

Who should not use Ovidrel® PreFilled Syringe (choriogonadotropin alfa injection)?

Ovidrel® PreFilled Syringe should not be used in patients who are pregnant or breastfeeding, in patients with primary ovarian failure (the ovaries no longer produce eggs), or in patients with allergies to hCG or any other ingredients in the medication.

Patients with cancer of the sex organs or brain, or with uncontrolled thyroid or adrenal disease, should not use Ovidrel® PreFilled Syringe. Women with a history of abnormal bleeding from the uterus or vagina or with swollen, enlarged, or painful ovaries should speak to their doctor before starting treatment.

In infertile women undergoing assisted reproductive technologies (ART) and ovulation induction (OI), Ovidrel® PreFilled Syringe should not be administered until adequate follicular development is indicated by serum estradiol and vaginal ultrasonography.

Ovidrel® PreFilled Syringe administration should be withheld in situations where there is an excessive ovarian response, as evidenced by multiple follicular development, clinically significant ovarian enlargement or excessive estradiol production.

What are the possible side effects of Ovidrel® PreFilled Syringe?

Your doctor should review with you the risks and benefits of using Ovidrel® PreFilled Syringe. As with any medication, report any and all side effects, symptoms, or physical changes to your doctor.

Use of fertility drugs can be associated with fertilization of more than one egg. This can lead to complications for the mother and the birth of two or more babies.

The most common side effects in women using Ovidrel® PreFilled Syringe include abdominal pain, nausea, and vomiting. Needle injections may cause some discomfort.

What are the uses of Ovidrel® PreFilled Syringe?
Ovidrel® PreFilled Syringe contains recombinant human choriogonadotropin alfa (hCG), an injectable hormone. This is the hormone that causes your eggs to finish maturing and be released. You may be given Ovidrel® PreFilled Syringe to complete this final stage of your cycle. Doctors specializing in infertility or reproductive health prescribe Ovidrel® PreFilled Syringe to those women trying to have a child but for a variety of reasons need medical assistance. After a thorough medical exam to determine your specific medical condition, your doctor may prescribe Ovidrel® PreFilled Syringe because you require hormone replacement or supplementation as part of your treatment program. Ovidrel® PreFilled Syringe may be one of several drugs prescribed to a patient as part of a treatment program.

Cetrotide® should not be used in patients who are pregnant, think they might be pregnant, or are breastfeeding.

Cetrotide® should not be used in patients with kidney disease.

Patients that are allergic to cetrorelix acetate, mannitol, or exogenous peptide hormones – medicines similar to Cetrotide®-should not use Cetrotide®. Consult your doctor before taking Cetrotide® if you have had severe allergic reactions.

What are the possible side effects of Cetrotide®?

Your doctor should review with you the risks and benefits of using Cetrotide®. As with any medication, report any and all side effects, symptoms, or physical changes to your doctor.

Mild and short-lasting reactions may occur at the injection site like reddening, itching, and swelling. Nausea and headache have also been reported.

Call your doctor if you have any other side effect or if you are unsure about the effect of this medicine.

What are the uses of Cetrotide®?

Cetrotide® blocks the effects of a natural hormone, called gonadotropin-releasing hormone (GnRH). GnRH controls the secretion of another hormone, called luteinizing hormone (LH), which induces ovulation during the menstrual cycle.

During hormone treatment for ovarian stimulation, premature ovulation may lead to eggs that are not suitable for fertilization. Cetrotide® blocks such undesirable premature ovulation.

This site contains medical information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.

IMPORTANT RISK INFORMATION AND INDICATION

Do not use Gonal-f® RFF* Redi-ject® (follitropin alfa injection) if you:

have a tumor in your female organs, including your ovaries, breast, or uterus

have a tumor in your brain, such as a tumor in your pituitary or hypothalamus

have abnormal bleeding from your uterus or vagina

have ovarian cysts or large ovaries, not due to polycystic ovary syndrome (PCOS)

Before you use Gonal-f® RFF* Redi-ject®, tell your healthcare provider if you:

have or have had asthma

have been told by a healthcare provider that you have an increased risk for blood clots (thrombosis)

have ever had a blood clot (thrombosis), or anyone in your family has ever had a blood clot (thrombosis)

have had abdominal surgery

have had twisting of your ovary (ovarian torsion)

had or have a cyst on your ovary

have polycystic ovarian disease

have any other medical conditions

are breastfeeding or plan to breastfeed

are taking any other prescription or over-the-counter medicines, vitamins, and herbal supplements

Gonal-f® RFF* Redi-ject®may cause serious side effects, including:

severe allergic reactions in women who have used Gonal-f®, Gonal-f® RFF*, or Gonal-f® RFF* Redi-ject® in the past. New allergic reactions can occur immediately after an injection. Severe allergic reaction may lead to death. If you have any of the following symptoms of a severe allergic reaction, stop using Gonal-f® RFF* Redi-ject® and go to the hospital right away:

shortness of breath

swelling of your face

itchy, red bumps or rash on your skin (hives)

ovaries that are too large; symptoms of bloating or pain in your lower stomach (pelvic) area.

ovarian hyperstimulation syndrome (OHSS); a serious medical condition that can happen when your ovaries produce too many eggs (overstimulated). OHSS can cause fluid to suddenly build up in the area of your stomach, chest, and heart, and can cause blood clots to form. In rare cases OHSS has caused death. OHSS may also happen after you stop using Gonal-f® RFF* Redi-ject®. Stop using Gonal-f® RFF* Redi-ject® and call your healthcare provider right away if you have symptoms of OHSS, including:

twisting (torsion) of your ovary if you already have certain conditions such as ovarian cysts, OHSS, pregnancy and previous abdominal surgery. Twisting of your ovary may lead to blood flow being cut off to your ovary.

pregnancy with more than 1 baby and birth of multiple babies; Having a pregnancy and giving birth to multiple babies at a time increases the health risk for you and your babies. Your healthcare provider should tell you about your chances of multiple births.

birth defects in a baby born after an ART cycle (IVF or ICSI). Your chances of having a baby with birth defects may increase depending on:

your age

certain sperm problems

your genetic background and that of your partner

a pregnancy with more than 1 baby at a time

ectopic pregnancy (pregnancy outside your womb). Your chance of having a pregnancy outside of your womb is increased if you also have fallopian tube problems.

miscarriage. Your chance of loss of an early pregnancy may be increased if you had difficulty becoming pregnant.

tumors of the ovary. If you have used fertility medicines like Gonal-f® RFF* Redi-ject® (follitropin alfa injection) before to get pregnant, you may have an increased chance of having tumors in your ovary(ies) (including cancer).

The most common side effects of Gonal-f® RFF* Redi-ject® include:

headache

stomach pain

stomach bloating

bruising at the injection site

nausea

These are not all the possible side effects of Gonal-f® RFF* Redi-ject®. For more information, call your healthcare provider or pharmacist. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Do not share your Gonal-f® RFF* Redi-ject® and needles with another person. You may give another person an infection or get an infection from them.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Also read the Gonal-f® RFF* Redi-ject® “Instructions for Use” that comes with Pen for information about the correct use of Gonal-f® RFF* Redi-ject® and follow all training and instruction provided by your healthcare provider.

Who should not use Gonal-f® (follitropin alfa for injection) and Gonal-f® RFF* (follitropin alfa for injection)?

Gonal-f® Multi-Dose and Gonal-f® RFF* should not be used in patients who are pregnant or think they might be pregnant, in patients with primary ovarian failure (the ovaries no longer produce eggs), or in patients with allergies to recombinant human FSH products or any other ingredients in the medication.

Patients with cancer of the sex organs or brain, or with uncontrolled thyroid or adrenal disease, should not use Gonal-f® Multi-Dose or Gonal-f® RFF*. Women with a history of abnormal bleeding from the uterus or vagina or with swollen, enlarged, or painful ovaries should speak to their doctor before starting treatment.

What are the possible side effects of Gonal-f® and Gonal-f® RFF*?

The lowest dose expected to achieve the desired results should be used. A doctor should monitor a woman’s response often to avoid overdose, which can lead to serious side effects, including blood clots.

Women should contact their doctor if severe pain or bloating in the stomach or pelvic area, severe upset stomach, vomiting, or weight gain are experienced during treatment. These could be signs of a rare but serious condition known as Ovarian Hyperstimulation Syndrome, or OHSS, which can result in hospitalization.

Use of Gonal-f® Multi-Dose or Gonal-f® RFF* by a woman can be associated with fertilization of more than 1 egg. This can lead to complications for the woman and the birth of 2 or more babies.

The most common side effects reported by women were headache, ovarian cysts, upset stomach, and sinus infection. The most common side effects reported by men taking Gonal-f® Multi-Dose were skin pimples, breast pain and growth, and tiredness. Injections may cause some discomfort.

What are the uses of Gonal-f® (follitropin alfa for injection) and Gonal-f®RFF* (follitropin alfa for injection)?

Gonal-f® Multi-Dose and Gonal-f® RFF* are 2 products that contain follitropin alfa, which is similar to the human hormone follicle-stimulating hormone, referred to as FSH. FSH belongs to a group of human reproductive hormones.

Gonal-f® Multi-Dose and Gonal-f® RFF* are used in certain infertile women to help with ovulation (production and release of a mature egg) and pregnancy. Gonal-f® will not help women whose ovaries no longer work because of a condition called Primary Ovarian Failure. Gonal-f® may also be used in women who are in an Assisted Reproductive Technology (ART) program such as in vitro fertilization to help their ovaries make more eggs.

Gonal-f® Multi-Dose can also be prescribed to increase sperm production in men with a rare condition that affects sperm production.

Both products should be prescribed only by doctors specializing in infertility problems and their treatment.

Who should not use Ovidrel® PreFilled Syringe (choriogonadotropin alfa injection)?

Ovidrel® PreFilled Syringe should not be used in patients who are pregnant or breastfeeding, in patients with primary ovarian failure (the ovaries no longer produce eggs), or in patients with allergies to hCG or any other ingredients in the medication.

Patients with cancer of the sex organs or brain, or with uncontrolled thyroid or adrenal disease, should not use Ovidrel® PreFilled Syringe. Women with a history of abnormal bleeding from the uterus or vagina or with swollen, enlarged, or painful ovaries should speak to their doctor before starting treatment.

In infertile women undergoing assisted reproductive technologies (ART) and ovulation induction (OI), Ovidrel® PreFilled Syringe should not be administered until adequate follicular development is indicated by serum estradiol and vaginal ultrasonography.

Ovidrel® PreFilled Syringe administration should be withheld in situations where there is an excessive ovarian response, as evidenced by multiple follicular development, clinically significant ovarian enlargement or excessive estradiol production.

What are the possible side effects of Ovidrel® PreFilled Syringe?

Your doctor should review with you the risks and benefits of using Ovidrel® PreFilled Syringe. As with any medication, report any and all side effects, symptoms, or physical changes to your doctor.

Use of fertility drugs can be associated with fertilization of more than one egg. This can lead to complications for the mother and the birth of two or more babies.

The most common side effects in women using Ovidrel® PreFilled Syringe include abdominal pain, nausea, and vomiting. Needle injections may cause some discomfort.

What are the uses of Ovidrel® PreFilled Syringe?
Ovidrel® PreFilled Syringe contains recombinant human choriogonadotropin alfa (hCG), an injectable hormone. This is the hormone that causes your eggs to finish maturing and be released. You may be given Ovidrel® PreFilled Syringe to complete this final stage of your cycle. Doctors specializing in infertility or reproductive health prescribe Ovidrel® PreFilled Syringe to those women trying to have a child but for a variety of reasons need medical assistance. After a thorough medical exam to determine your specific medical condition, your doctor may prescribe Ovidrel® PreFilled Syringe because you require hormone replacement or supplementation as part of your treatment program. Ovidrel® PreFilled Syringe may be one of several drugs prescribed to a patient as part of a treatment program.

Cetrotide® should not be used in patients who are pregnant, think they might be pregnant, or are breastfeeding.

Cetrotide® should not be used in patients with kidney disease.

Patients that are allergic to cetrorelix acetate, mannitol, or exogenous peptide hormones – medicines similar to Cetrotide®-should not use Cetrotide®. Consult your doctor before taking Cetrotide® if you have had severe allergic reactions.

What are the possible side effects of Cetrotide®?

Your doctor should review with you the risks and benefits of using Cetrotide®. As with any medication, report any and all side effects, symptoms, or physical changes to your doctor.

Mild and short-lasting reactions may occur at the injection site like reddening, itching, and swelling. Nausea and headache have also been reported.

Call your doctor if you have any other side effect or if you are unsure about the effect of this medicine.

What are the uses of Cetrotide®?

Cetrotide® blocks the effects of a natural hormone, called gonadotropin-releasing hormone (GnRH). GnRH controls the secretion of another hormone, called luteinizing hormone (LH), which induces ovulation during the menstrual cycle.

During hormone treatment for ovarian stimulation, premature ovulation may lead to eggs that are not suitable for fertilization. Cetrotide® blocks such undesirable premature ovulation.

This site contains medical information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.

You are now leaving Fertility LifeLines™

You have selected a link to a third-party website. This link is provided solely as a convenience to you and not as an endorsement by Fertility LifeLines™ of such third-party website. Fertility LifeLines™ is not responsible for and does not make any representations regarding the accuracy of materials on such third-party site.